Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

The impact of comorbidities on the obstructive sleep apnea

Show simple item record

dc.contributor.author Avram, Liviu
dc.date.accessioned 2020-10-19T07:12:24Z
dc.date.available 2020-10-19T07:12:24Z
dc.date.issued 2020
dc.identifier.citation AVRAM, Liviu. The impact of comorbidities on the obstructive sleep apnea. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 144-145. en_US
dc.identifier.uri https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/12216
dc.description Department of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 en_US
dc.description.abstract Introduction. Obstructive sleep apnoea (OSA) is highly prevalent and there is considerable evidence supporting an independent association with a wide range of co-morbidities including cardiovascular, endocrine and metabolic, neuropsychiatric, pulmonary, and renal. Aim of the study. The objective of this study is to assess the prevalance of major comorbidities associated with obstructive sleep apnea (OSA) and to examine the predictive role of Charlson comorbidity index (CCI) on mortality of patients with OSA associated with comorbidities. Materials and methods. This is a cross-sectional study of 67 patients diagnosed with OSA based on antropometric dates,cardiorespiratory polygraphy and AHI.Inclusion criteria were patients with diagnosis of OSA, who were aged 18 and above and had comorbidities. We assess patients with comorbodities through Charlson index adapted to International Classification of Disease (ICD-10) codes. Charlson Comorbidity Index (CCI) (Charlson et al., 1987) quantifies an individual’s burden of disease and corresponding 1-year mortality risk. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a patient. A score of zero indicates that no comorbidities were found. The higher the score, the more likely the predicted outcome will result in mortality or higher resource use. Results. We evaluated 67 patients with OSA (51 men and 16 women) with a mean age of 53.9 years (range 25–76 years). The prevalence of comorbidities were: hypertension (91%), obesity (85%), congestive heart failure (65%), pulmonary hypertension (26%), diabetes mellitus (25%), coronary heart disease (22%), etc. Based on the Charlson index of comorbidity the weighted index of comorbidity were: 0 for 6 patients, 1 for 17 patients,2 for 13 patients,3 for 13 patients,4 for 11 patients, 5 for 5 patients and 6 for 2 patients. Combined condition and agerelated score were: 0 for 2 patients,1 for 8 patients,2 for 10 patients, 3 for 12 patients,4 for 9 patients,5 for 8 patients,6 for 10 patients.7 for 1 patient and 8 for 1 patient.Patients with combined condition and age related score of 0 (2) estimated 10 year survival was 98 %, 1 (8) was 96%, 2 (10) was 90 %,3(12) was 77 %, 4 (9) was 53 %, 5 (9) was 21 %,6 was 2 %,7 was 0 %,8 was 0 %.Conclusions. Our study revealed that exists a strength association between 10 year survival rate and other two factors: age related score and weighted index of comorbidity.The cardiovascular diseases are the most predominant comorbidities at OSA patients.The patients with higher CCI scores had higher risk of mortality. The impact of comorbidities on the obstructive sleep apnea is significant. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject Obstructive sleep apneea(OSA) en_US
dc.subject comorbidity en_US
dc.subject Charlson index of comorbidity(CCI) en_US
dc.title The impact of comorbidities on the obstructive sleep apnea en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2020
    The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics